Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an α4 integrin inhibitor

Abstract

Natalizumab had no abortifacient or teratogenic effects, but was associated with changes in fetal hematopoiesis and leukocyte trafficking.